$INJ You'll surprise me again. BACK IN THE GAME: INSTITUTIONAL INTEREST COULD BECOME A CATALYST
Injective has come sharply back to life: on October 16, news reports noted that the token had risen around 27% in 24 hours, reaching about $9.35. Reports of the team meeting with U.S. regulators and new opportunities for institutional access also drew attention.
There’s another concrete factor: applications for investment products linked to $INJ were filed in October by 21Shares, Canary, and REX-Osprey. Applications aren’t approvals, but they show that traditional financial market participants are considering the project.
My benchmark: holding the $9 area after a sharp surge would strengthen the recovery outlook. The next psychological level is $10. A sustained move above it would make the rally more convincing.
#INJ #Injective #Altcoins #Crypto
Injective has come sharply back to life: on October 16, news reports noted that the token had risen around 27% in 24 hours, reaching about $9.35. Reports of the team meeting with U.S. regulators and new opportunities for institutional access also drew attention.
There’s another concrete factor: applications for investment products linked to $INJ were filed in October by 21Shares, Canary, and REX-Osprey. Applications aren’t approvals, but they show that traditional financial market participants are considering the project.
My benchmark: holding the $9 area after a sharp surge would strengthen the recovery outlook. The next psychological level is $10. A sustained move above it would make the rally more convincing.
#INJ #Injective #Altcoins #Crypto